Pilot Study Assesses AI-Guided Cardiac Ultrasound

• by Kathryn Wighton

• June 26, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min

FDA updates PAH label with trial data

In adults diagnosed with pulmonary arterial hypertension within the previous year, adding sotatercept to background therapy reduced the risk of clinical worsening events by 76% compared with placebo.

• by Kathryn Wighton

• September 22, 2026

• 3 min

Echocardiography-derived hemodynamic forces in cardiac resynchronization therapy: association with reverse remodeling and long-term outcomes

• by Roberto Tarantini, Willem Gerrits, Cheyenne S.L. Chiu, Leonie Smit, Gilbert Heltzel, Luuk H.G.A. Hopman, Philippe C. Wouters, Maarten J. Cramer, Frebus J. van Slochteren, Rene van Es, Alexander H. Maass, Michiel Rienstra, Cornelis P. Allaart, Kevin Vernooy, Antonius M.W. van Stipdonk, Frederik J. de Lange, Dorien Laenens, Philippe van Rosendael, Jeroen J. Bax, Nina Ajmone Marsan

• September 9, 2026